McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205–19.

Article  CAS  PubMed  Google Scholar 

Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320:1360–72.

Article  PubMed  Google Scholar 

Kinne RW, Bräuer R, Stuhlmüller B, Palombo-Kinne E, Burmester GR. Macrophages in rheumatoid arthritis. Arthritis Res. 2000;2:189–202.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu Y, Zhang Z, He J, Chen Z. Immune effects of macrophages in rheumatoid arthritis: a bibliometric analysis from 2000 to 2021. Front Immunol. 2022;13:903771.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang X, Chang Y, Wei W. Emerging role of targeting macrophages in rheumatoid arthritis: Focus on polarization, metabolism and apoptosis. Cell Prolif. 2020;53:12854.

Article  Google Scholar 

Liu Y, Xu R, Gu H, Zhang E, Qu J, Cao W, et al. Metabolic reprogramming in macrophage responses. Biomark Res. 2021;9:1.

Article  PubMed  PubMed Central  Google Scholar 

Yu Q, Wang Y, Dong L, He Y, Liu R, Yang Q, et al. Regulations of glycolytic activities on macrophages functions in tumor and infectious inflammation. Front Cell Infect Microbiol. 2020;10:287.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bae S, Park PSU, Lee Y, Mun SH, Giannopoulou E, Fujii T, et al. MYC-mediated early glycolysis negatively regulates proinflammatory responses by controlling IRF4 in inflammatory macrophages. Cell Rep. 2021;35:109264.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie Y, Feng SL, Mai CT, Zheng YF, Wang H, Liu ZQ, et al. Suppression of up-regulated LXRα by silybin ameliorates experimental rheumatoid arthritis and abnormal lipid metabolism. Phytomedicine: Int J Phytother Phytopharmacol. 2021;80:153339.

Article  CAS  Google Scholar 

Asquith DL, Ballantine LE, Nijjar JS, Makdasy MK, Patel S, Wright PB, et al. The liver X receptor pathway is highly upregulated in rheumatoid arthritis synovial macrophages and potentiates TLR-driven cytokine release. Ann Rheum Dis. 2013;72:2024–31.

Article  CAS  PubMed  Google Scholar 

Aleja AG, Herrero C, Torres-Torresano M, Schiaffino MT, Del Castillo A, Alonso B, et al. Inhibition of LXR controls the polarization of human inflammatory macrophages through upregulation of MAFB. Cell Mol Life Sci. 2023;80:96.

Article  PubMed  PubMed Central  Google Scholar 

Ménégaut L, Jalil A, Pilot T, Dongen K, Crespy V, Steinmetz E, et al. Regulation of glycolytic genes in human macrophages by oxysterols: a potential role for liver X receptors. Br J Pharmacol. 2021;178:3124–39.

Article  PubMed  Google Scholar 

Repa JJ, Mangelsdorf DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu Rev Cell Dev Biol. 2000;16:459–81.

Article  CAS  PubMed  Google Scholar 

Flaveny CA, Griffett K, El-Gendy Bel D, Kazantzis M, Sengupta M, Amelio AL, et al. Broad anti-tumor activity of a small molecule that selectively targets the Warburg effect and lipogenesis. Cancer Cell. 2015;28:42–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Inglis JJ, Criado G, Medghalchi M, Andrews M, Sandison A, Feldmann M, et al. Collagen-induced arthritis in C57BL/6 mice is associated with a robust and sustained T-cell response to type II collagen. Arthritis Res Ther. 2007;9:113.

Article  Google Scholar 

Qu B, Wang XL, Zheng DC, Mai CT, Liu ZQ, Zhou H, et al. Novel treatment for refractory rheumatoid arthritis with total glucosides of paeony and nobiletin codelivered in a self-nanoemulsifying drug delivery system. Acta Pharmacol Sin. 2022;43:2094–108.

Article  CAS  PubMed  Google Scholar 

Zheng D, Liu Z, Zhou Y, Hou N, Yan W, Qin Y, et al. Urolithin B, a gut microbiota metabolite, protects against myocardial ischemia/reperfusion injury via p62/Keap1/Nrf2 signaling pathway. Pharmacol Res. 2020;153:104655.

Article  CAS  PubMed  Google Scholar 

Luise M, Sollazzo M, Lama E, Coadă CA, Bressi L, Iorio M, et al. Inducing respiratory complex I impairment elicits an increase in PGC1α in ovarian cancer. Sci Rep. 2022;12:8020.

Article  PubMed  PubMed Central  Google Scholar 

Zhang F, Wei K, Slowikowski K, Fonseka CY, Rao DA, Kelly S, et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol. 2019;20:928–42.

Article  PubMed  PubMed Central  Google Scholar 

Alten R, Gram H, Joosten LA, Berg WB, Sieper J, Wassenberg S, et al. The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis. Arthritis Res Ther. 2008;10:67.

Article  Google Scholar 

Alten R, Gomez-Reino J, Durez P, Beaulieu A, Sebba A, Krammer G, et al. Efficacy and safety of the human anti-IL-1β monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, Phase II, dose-finding study. BMC Musculoskelet Disord. 2011;12:153.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Siebert S, Tsoukas A, Robertson J, McInnes I. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases. Pharmacol Rev. 2015;67:280–309.

Article  CAS  PubMed  Google Scholar 

Cai W, Cheng J, Zong S, Yu Y, Wang Y, Song Y, et al. The glycolysis inhibitor 2-deoxyglucose ameliorates adjuvant-induced arthritis by regulating macrophage polarization in an AMPK-dependent manner. Mol Immunol. 2021;140:186–95.

Article  CAS  PubMed  Google Scholar 

Byles V, Covarrubias AJ, Ben-Sahra I, Lamming DW, Sabatini DM, Manning BD, et al. The TSC-mTOR pathway regulates macrophage polarization. Nat Commun. 2013;4:2834.

Article  PubMed  Google Scholar 

Kelly B, O’Neill LA. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 2015;25:771–84.

Article  PubMed  PubMed Central  Google Scholar 

Savla SR, Prabhavalkar KS, Bhatt LK. Liver X receptor: a potential target in the treatment of atherosclerosis. Expert Opin Ther Targets. 2022;26:645–58.

Article  CAS  PubMed  Google Scholar 

Li N, Li Y, Han X, Zhang J, Han J, Jiang X, et al. LXR agonist inhibits inflammation through regulating MyD88 mRNA alternative splicing. Front Pharmacol. 2022;13:973612.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Im SS, Osborne TF. Liver x receptors in atherosclerosis and inflammation. Circ Res. 2011;108:996–1001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thomas DG, Doran AC, Fotakis P, Westerterp M, Antonson P, Jiang H, et al. LXR suppresses inflammatory gene expression and neutrophil migration through cis-repression and cholesterol efflux. Cell Rep. 2018;25:3774–85.e4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Griffett K, Solt LA, El-Gendy B-D, Kamenecka TM, Burris TP. A liver-selective LXR inverse agonist that suppresses hepatic steatosis. ACS Chem Biol. 2013;8:559–67.

Article  CAS  PubMed  Google Scholar 

Griffett K, Welch RD, Flaveny CA, Kolar GR, Neuschwander-Tetri BA, Burris TP. The LXR inverse agonist SR9238 suppresses fibrosis in a model of non-alcoholic steatohepatitis. Mol Metab. 2015;4:353–7.